Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
MAFG - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
PSMB2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IRAK4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PSMF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PEX16 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MIR4738 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AQP3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MRPS18A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GM2A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CCDC25 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SQRDL - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HEXB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FBXO7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IK - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMEM234 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NEU1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DDOST - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LMNA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MGAT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on